Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies-Reference-Cited by-同舟云学术

Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies

Published:2019-01-16 Issue:2 Volume:42 Page:159-179
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Procaccio Letizia,Damuzzo Vera,Di Sarra Francesca,Russi Alberto,Todino Federica,Dadduzio Vincenzo,Bergamo Francesca,Prete Alessandra Anna,Lonardi Sara,Prenen Hans,Palozzo Angelo Claudio,Loupakis Fotios^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

http://link.springer.com/content/pdf/10.1007/s40264-018-0776-6.pdf

Reference170 articles.

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182–6.

2. Wildiers H, Guetens G, De Boeck G, Verbeken E, Landuyt B, Landuyt W, et al. Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11. Br J Cancer. 2003;88(12):1979–86.

3. Bagri A, Berry L, Gunter B, Singh M, Kasman I, Damico LA, et al. Effects of anti-VEGF treatment duration on tumor growth, tumor regrowth, and treatment efficacy. Clin Cancer Res. 2010;16(15):3887–900. https://doi.org/10.1158/1078-0432.CCR-09-3100 .

4. Heijmen L, Punt CJA, Ter Voert EGW, de Geus-Oei LF, Heerschap A, Bussink J, et al. Monitoring the effects of bevacizumab beyond progression in a murine colorectal cancer model: a functional imaging approach. Invest New Drugs. 2013;31(4):881–90. https://doi.org/10.1007/s10637-012-9920-9 .

5. Escudier B, Szczylik C, Porta C, Gore M. Treatment selection in metastatic renal cell carcinoma: expert consensus. Nat Rev Clin Oncol. 2012;9(6):327–37. https://doi.org/10.1038/nrclinonc.2012.59 .

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Hub Genes Associated with the Progression and Prognosis of Gastric Cancer through Systematic Bioinformatics Analysis;2024-07-15

2. Research progress on the structure, function, and use of angiogenin in malignant tumours;Heliyon;2024-05

3. Uncovering Knowledge Gaps in the Safety Profile of Antiangiogenic Drugs in Cancer Patients: Insights from Spontaneous Reporting Systems Studies;Pharmaceuticals;2023-06-12

4. Common strategies for effective immunotherapy of gastroesophageal cancers using immune checkpoint inhibitors;Pathology - Research and Practice;2022-10

5. Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy;Evidence-Based Complementary and Alternative Medicine;2022-08-10